Navigation Links
WHO Awards Prequalification Status to the First UAE Approved Vaccine

is a two-dose, oral vaccine that is administered at approximately two and four months of age to offer early protection against rotavirus infection. The vaccine has already been licensed in 90 countries and 11 million doses of the vaccine have been distributed since its first launch in Mexico in 2004.The UAE was one of the first countries to register for this vaccination and is the first country in the Middle East to have this vaccine.

"Rotavirus causes great discomfort for children, with diarrhea and vomiting continuing for several days, which can lead to severe dehydration, and if left untreated, can be fatal. The availability of a safe and effective vaccine, like Rotarix, is a relief for physicians as it will not only prevent these distressing symptoms that many children suffer, but will also help to reduce the burden on healthcare resources needed in treating outbreaks of the disease," commented Dr. KhanA.Shahzad, specialist pediatrician at kids’ first medical center, visiting consultant at American hospital.

Source-Bio-Bio Technology'"/>




Page: 1 2

Related medicine news :

1. Aussie Nobel Prize Winners Receive Their Awards
2. Prestigious Gairdner Awards for medical research in 2006 Goes To Two Yale biologists
3. The President Gives Away National Disability Awards
4. Majority of Padma Awards Go to Doctors from Delhi
5. US, Indian Doctors Bag Thai Medical Awards
6. Bio-Rad Gets Life Science Industry Awards – 200
7. Status of some prescription drugs
8. Low Socioeconomic Status May Lead To Mental Illness
9. Post-Menopausal Status May Cause Tooth Decay
10. Ruling On Non Disclosure Of HIV Positive Status Is Not Ethical
11. Treatment For Prostate Cancer Relapse Linked To Marital Status
Post Your Comments:
(Date:9/5/2008)...pt. 5 /PRNewswire-USNewswire/ -- U.S. citizens can... Cuban victims of Hurricane,Gustav, which is the w.../www.PanAmericanRelief.org ), "Donations will be ...ed,after this natural disaster," says Marc Wachten... at the Pan American Development Foundation, (http...
(Date:9/5/2008)...pt. 5 /PRNewswire-USNewswire/ -- As the general el...nal Federation of Independent,Business ( http://ww...ndidates for a greater focus on the healthcare con...nd Republican conventions are over, NFIB,is asking... obstacles faced,by small businesses as they furth...
(Date:9/5/2008)...ds sorafenib helps reverse disease resistance to a... (HealthDay News) -- The drug sorafenib may help "...-hormonal drugs, Georgetown University Medical Ce...eptor or progesterone-receptor positive (ER or PR ...i-hormonal medicines, such as aromatase inhibitors...
(Date:9/5/2008)...men with hormone-receptor positive, metastatic bre...keep their cancer at bay, but when the tumor becom...h chemotherapy becomes the only option. But a stud...ymposiummay change this approach. Early data sugg...he tumor, allowing anti-hormonal drugs to do their...
Breaking Medicine News(10 mins):Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2Health News:1 step back ... 2 steps forward 2
...in damage. On the contrary brain damage occurs onl...scovered by researchers from San Francisco VA Medi... results may have implications on the treatment of...detailed research is necessary before it can be ap...
...at from mid-February to mid-March it distributed f...per every man// living in the city, as part of its...epartment in January approved a $1.57 million cont...festyle condoms and packets of lubricants to organ...
...believe a brain imaging approach that combines sta...h specialized contrast-enhanced techniques could l...ifficult-to-detect blood clots in veins of the bra...ndings in the April issue of the American Journal ...
...ppiness of her 27th marriage anniversary, extremel...n to suffer// hot flashes, she dismissed them as p...nant, but didn’t think so even in her wildest drea... back pain, were attributed to symptoms of advanci...
Other Medicine News:Health News:Glucose Causes Death of Brain Cells in Rodents Following Hypoglycemic Coma 2Health News:Glucose Causes Death of Brain Cells in Rodents Following Hypoglycemic Coma 3Health News:New York Health Department Distributes Five Million Condoms in a Month 2Health News:Combined Imaging Approach may Be Effective in Diagnosing Some Brain Clots 2
(Date:9/4/2008)...ented at ESC Congress-, PHILADELPHIA, Sept. 4 /PR...y, the GISSI Heart Failure (GISSI-HF) study, showe...uced all cause mortality and hospital,admissions f... heart,failure. These findings are published in th...presented at the European Cardiovascular Society (...
(Date:9/4/2008)...e Than 100 Sites in the U.S., ANN ARBOR, Mich., S...rivately-held biopharmaceutical company focused on... treat endocrine, metabolic and,cardiovascular dis...cond,Phase 3 clinical trial of Ophena(TM) (ospemif...rapy in development for the treatment of vaginal,s...
(Date:9/4/2008)...ctivity and favorable safety ...Newswire-FirstCall/ -- Idenix,Pharmaceuticals, Inc...gaged,in the discovery and development of drugs fo...s diseases, today announced that it has completed ...n-nucleoside reverse,transcriptase inhibitor (NNRT...
(Date:9/3/2008)...re-FirstCall/ --,Pharmaceutical company Pharmaxis ...as enrolled the first subject into its second pivo...n cystic fibrosis sufferers., The Phase 3 trial i...rica, Argentina and Germany, and is the final clin...t Bronchitol for cystic fibrosis in the,United Sta...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Vestergaard Frandsen to Launch High Tech Filter to Provide Clean and Safe Drinking Water to People in Developing Nations 11047 1Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells 11044 1Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells 11044 2Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells 11044 3Collaboration needed for strengthening medical research in Europe 11040 1Collaboration needed for strengthening medical research in Europe 11040 2Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells 1321 1Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells 1321 2Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells 1321 3
...d with Development Program for Oral Compounds,to ...INESS WIRE)--July 2, 2007--Alkermes, Inc.,(Nasdaq:...s from a,clinical trial of ALKS 29 in alcohol depe...y plans to move forward with its,development progr...pendence. ALKS 29 is a combination of two agents w...
...WIRE)--Jul 2, 2007 - Ceragenix Pharmaceuticals,In...ed on,infectious disease and dermatology, today an...sylvania led by Dr. Paul,Janmey and Dr. Robert Buc...igham Young University, have demonstrated in a ser...l drug compound known,as CSA-13 shows promise as a...
Other Medicine Technology:Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 2Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 3Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 4Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 2Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 3Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 4
...A lower cost alternative to Equalizers, the patent...ransfers between two different vessel configuratio...an be quickly and easily adjusted for test tubes (...onomic Design for Unparalleled Comfort Pick one o...
...A lower cost alternative to Equalizers, the patent...ransfers between two different vessel configuratio...an be quickly and easily adjusted for test tubes (...onomic Design for Unparalleled Comfort Pick one o...
...A lower cost alternative to Equalizers, the patent...ransfers between two different vessel configuratio...an be quickly and easily adjusted for test tubes (...onomic Design for Unparalleled Comfort Pick one o...
...A lower cost alternative to Equalizers, the patent...ransfers between two different vessel configuratio...an be quickly and easily adjusted for test tubes (...onomic Design for Unparalleled Comfort Pick one o...
Medicine Products: